CARMAT

Corporate Details

ISIN(s):

FR0010907956

LEI:

969500ARXACM0P0KH333

Country:

France

Address:

36 AVENUE DE L'EUROPE, 78140 VELIZY-VILLACOUBLAY

Website:

https://www.carmatsa.com/en/

Sector:

Health Care

Industry:

Health Care Equipment & Supplies

Description

CARMAT is a French MedTech that designs, manufactures and markets the Aeson® artificial heart. The Company’s ambition is to make Aeson® the first alternative to a heart transplant, and thus provide a therapeutic solution to people suffering from end-stage biventricular heart failure, who are facing a well-known shortfall in available human grafts. The world’s first physiological artificial heart that is highly hemocompatible, pulsatile and self-regulated, Aeson® could save, every year, the lives of thousands of patients waiting for a heart transplant. The device offers patients quality of life and mobility thanks to its ergonomic and portable external power supply system that is continuously connected to the implanted prosthesis. Aeson® is commercially available as a bridge to transplant in the European Union and other countries that recognize CE marking. Aeson® is also currently being assessed within the framework of an Early Feasibility Study (EFS) in the United States.